[9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]ISOQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO

Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: wherein R1 is as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, hyperkinetic di...

Full description

Saved in:
Bibliographic Details
Main Authors ASHWEEK NEIL, HARRIOTT NICOLE
Format Patent
LanguageChinese
English
Published 05.12.2017
Subjects
Online AccessGet full text

Cover

More Information
Summary:Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: wherein R1 is as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, hyperkinetic disorders. Also disclosed are compositions containing these compounds in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use in a subject in need thereof. 具有式(I)结构的化合物,包括其立体异构体以及药物可接受的盐和溶剂化物:其中R如本文定义。这类化合物是囊泡单胺转运体2(VMAT2)的抑制剂,并且具有治疗例如运动机能亢进性病症的效用。还公开了含有这些化合物结合药物可接受的载体的组合物,以及涉及对有需要的个体使用的方法。
Bibliography:Application Number: CN20168008945